Physician profile
Michael J Abboud
NPI 1568632263
$733.92
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $33.63 · 2021: $59.88 · 2022: $125 · 2023: $104 · 2024: $78.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.27 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $140.58 | 2019-2024 | Echelon Flex, Echelon; Endopath |
| Astrazeneca Pharmaceuticals Lp | $124.99 | 2022 | |
| Glaxosmithkline, LLC. | $112.23 | 2019 | |
| Integra Lifesciences Corporation | $79.88 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Davol INC. | $43.72 | 2019 | |
| Baxter Healthcare | $36.32 | 2019 | |
| Kci USA, INC. | $32.36 | 2019-2023 | Prevena, V.A.C. Veraflo, Activ.A.C. |
| Innocoll Pharmaceuticals Limited | $28.61 | 2021 | |
| Focal Therapeutics, INC. | $28.30 | 2019 | |
| Z-Medica, LLC | $22.22 | 2019 | |
| Intuitive Surgical, INC. | $21.00 | 2019 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Solventum Corporation | $16.06 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C. Veraflo |
| Tela Bio, INC. | $15.37 | 2019 | |
| Pfizer INC. | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Abboud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.